莫西沙星治疗下呼吸道感染的临床研究

目的评价莫西沙星治疗下呼吸道感染的临床疗效与安全性。方法评价病例99例,随机分为试验组50例,对照组49例,试验组静脉滴注莫西沙星注射剂400 mg;1次/d,对照组静脉滴注左氧氟沙星注射剂400 mg,1次/d,疗程均为7~14 d。结果试验组和对照组的临床有效率分别为94.0%和79.6%,细菌清除率分别为94.3%和77.8%,两组临床有效率及细菌清除率比较差异均有统计学意义(P<0.05);试验组和对照组不良反应发生率分别为6.0%和8.2%,两组比较差异无统计学意义(P>0.05)。结论莫西沙星注射剂治疗下呼吸道感染疗效确切,安全性好,有较高的临床应用价值。

Moxifloxacin in Treatment of Lower Respiratory Tract Infection:Clinical Trials

OBJECTIVE To evaluate the efficacy and safety of moxifloxacin in treating lower respiratory infection.METHODS Totally 102 patients were enrolled in this study,but 3 cases were infixed or weeded.Fifty cases of trial group were given 400mg of moxifloxacin intravenously,once a day for 7-14 days,49 cases of control group were given 400mg of levofloxacin intravenously,once a day for 7-14 days.RESULTS The clinical efficacious rates of moxifloxacin and levofloxacin were 94.0% and 79.6%,respectively.The bacterial clearance rates of moxifloxacin and levofloxacin were 94.3% and 77.8%,respectively.There was significant difference(P<0.05) between two groups in the clinical efficacious rate and the bacterial clearance rate.The incidence of adverse drug reaction of moxifloxacin was 6.0% and of levofloxacin was 8.2%,There was no significant difference(P>0.05) between two groups.CONCLUSIONS Moxifloxacin injection is an effective and safe antibiotics for the treatment of lower respiratory tract infection.